Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study.
Janssens R, Lang T, Vallejo A, Galinsky J, Plate A, Morgan K, Cabezudo E, Silvennoinen R, Coriu D, Badelita S, Irimia R, Anttonen M, Manninen RL, Schoefs E, Vandebroek M, Vanhellemont A, Delforge M, Stevens H, Simoens S, Huys I. Janssens R, et al. Among authors: schoefs e. Front Med (Lausanne). 2021 Jul 6;8:686165. doi: 10.3389/fmed.2021.686165. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34295912 Free PMC article.
Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.
Monzani D, Petrocchi S, Oliveri S, Veldwijk J, Janssens R, Bailo L, Smith MY, Smith I, Schoefs E, Nackaerts K, Vandevelde M, Louis E, Decaluwé H, De Leyn P, Declerck H, Katz EG, Petrella F, Casiraghi M, Durosini I, Galli G, Garassino MC, de Wit GA, Pravettoni G, Huys I. Monzani D, et al. Among authors: schoefs e. Front Med (Lausanne). 2021 Aug 2;8:689114. doi: 10.3389/fmed.2021.689114. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34409049 Free PMC article.
Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.
Janssens R, Arnou R, Schoefs E, Petrocchi S, Cincidda C, Ongaro G, Oliveri S, Smith MY, Louis E, Vandevelde M, Nackaerts K, Pravettoni G, Huys I. Janssens R, et al. Among authors: schoefs e. Front Pharmacol. 2021 Sep 23;12:710518. doi: 10.3389/fphar.2021.710518. eCollection 2021. Front Pharmacol. 2021. PMID: 34630085 Free PMC article.
How to balance valuable innovation with affordable access to medicines in Belgium?
Simoens S, Abdallah K, Barbier L, Lacosta TB, Blonda A, Car E, Claessens Z, Desmet T, De Sutter E, Govaerts L, Janssens R, Lalova T, Moorkens E, Saesen R, Schoefs E, Vandenplas Y, Van Overbeeke E, Verbaanderd C, Huys I. Simoens S, et al. Among authors: schoefs e. Front Pharmacol. 2022 Sep 16;13:960701. doi: 10.3389/fphar.2022.960701. eCollection 2022. Front Pharmacol. 2022. PMID: 36188534 Free PMC article.
What are the Unmet Needs and Most Relevant Treatment Outcomes According to Patients with Inflammatory Bowel Disease? A Qualitative Patient Preference Study.
Schoefs E, Vermeire S, Ferrante M, Sabino J, Lambrechts T, Avedano L, Haaf I, De Rocchis MS, Broggi A, Sajak-Szczerba M, Saldaña R, Janssens R, Huys I. Schoefs E, et al. J Crohns Colitis. 2023 Apr 3;17(3):379-388. doi: 10.1093/ecco-jcc/jjac145. J Crohns Colitis. 2023. PMID: 36165579 Free PMC article. Review.
Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population.
Oliveri S, Lanzoni L, Petrocchi S, Janssens R, Schoefs E, Huys I, Smith MY, Smith IP, Veldwijk J, de Wit GA, Pravettoni G. Oliveri S, et al. Among authors: schoefs e. Patient Prefer Adherence. 2021 Nov 15;15:2509-2517. doi: 10.2147/PPA.S327006. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34848947 Free PMC article.
How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action.
Janssens R, Barbier L, Muller M, Cleemput I, Stoeckert I, Whichello C, Levitan B, Hammad TA, Girvalaki C, Ventura JJ, Bywall KS, Pinto CA, Schoefs E, Katz EG, Kihlbom U, Huys I. Janssens R, et al. Among authors: schoefs e. Front Pharmacol. 2023 Aug 16;14:1192770. doi: 10.3389/fphar.2023.1192770. eCollection 2023. Front Pharmacol. 2023. PMID: 37663265 Free PMC article.
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Oliveri S, Lanzoni L, Veldwijk J, de Wit GA, Petrocchi S, Janssens R, Schoefs E, Smith MY, Smith I, Nackaerts K, Vandevelde M, Louis E, Decaluwé H, De Leyn P, Declerck H, Petrella F, Casiraghi M, Galli G, Garassino MC, Girvalaki C, Huys I, Pravettoni G. Oliveri S, et al. Among authors: schoefs e. Front Psychol. 2023 Jun 21;14:1062830. doi: 10.3389/fpsyg.2023.1062830. eCollection 2023. Front Psychol. 2023. PMID: 37425173 Free PMC article.
What matters most to patients with multiple myeloma? A Pan-European patient preference study.
Janssens R, Lang T, Vallejo A, Galinsky J, Morgan K, Plate A, De Ronne C, Verschueren M, Schoefs E, Vanhellemont A, Delforge M, Schjesvold F, Cabezudo E, Vandebroek M, Stevens H, Simoens S, Huys I. Janssens R, et al. Among authors: schoefs e. Front Oncol. 2022 Nov 29;12:1027353. doi: 10.3389/fonc.2022.1027353. eCollection 2022. Front Oncol. 2022. PMID: 36523996 Free PMC article.